Alcon Takes A Poke In The Eye
Investopedia
Wed, 10/29/08 - 09:25 am
WSJ: Wyeth to curb research on women's health drugs
Marketwatch
Wed, 10/29/08 - 09:24 am
[video] Mad About Options: J&J in Review
The Street.com
Wed, 10/29/08 - 09:14 am
Vertex Pharma Promising, Volatile
Yahoo/Zacks.com
Wed, 10/29/08 - 09:14 am
Bayer Third-Quarter Net Fell 76.4% on Tax Benefit
Bloomberg
Wed, 10/29/08 - 09:00 am
J&J Units Must Pay $13 Million Over Pain-Patch Death, Jury Says
Bloomberg
Wed, 10/29/08 - 08:59 am
J&J deal marks preventive health move
Fierce Pharma
Tue, 10/28/08 - 11:39 am
When will the deluge of M&As hit?
Fierce Pharma
Tue, 10/28/08 - 11:39 am
Sepracor is seeking drug development partner
Boston Globe, MA
Tue, 10/28/08 - 11:37 am
Sepracor 3rd-quarter profit slides 51 percent on increased operating expenses
Yahoo/AP
Tue, 10/28/08 - 11:35 am
Rigel shares plunge on arthritis drug study
Marketwatch
Tue, 10/28/08 - 11:34 am
Clinical Data to acquire Avalon Pharmaceuticals
Marketwatch
Tue, 10/28/08 - 11:28 am
Provectus Announces Completion of Phase 1 Clinical Trial of PV-10 in Recurrent Breast Cancer
Yahoo
Tue, 10/28/08 - 11:00 am
Lilly Coughs It Up for ImClone
Yahoo/Zacks.com
Tue, 10/28/08 - 10:53 am
Rigel Shares Tank on Arthritis Data
The Street.com
Tue, 10/28/08 - 10:53 am
Is ImClone Really Worth More than $70 a Share?
WSJ Online
Tue, 10/28/08 - 10:49 am
Missing Forest Labs For The Trees
Investopedia
Tue, 10/28/08 - 10:48 am
Exelixis Q3 loss grows
Bizjournals.com
Tue, 10/28/08 - 10:48 am
Incyte arthritis drug shows potential in study
Yahoo/AP
Tue, 10/28/08 - 10:47 am
Potential Roadblock For Imclone Deal
Forbes
Tue, 10/28/08 - 10:46 am

Pages